Purity: SDS-PAGE

Anti-FOLR1 / FRA Reference Antibody (mirvetuximab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

Purity: SEC-HPLC

The purity of Anti-FOLR1 / FRA Reference Antibody (mirvetuximab) is 100%, determined by SEC-HPLC.

Bioactivity: ELISA

Immobilized human FRa His at 2 μg/mL can bind Anti-FOLR1 / FRA Reference Antibody (mirvetuximab), EC50=0.01123 μg/mL.

Bioactivity: FACS

SKOV3 cells were stained with Anti-FOLR1 / FRA Reference Antibody (mirvetuximab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.03238 μg/mL.

Function：Internalization

The endocytosis ratio mirvetuximab by Human Frα HEK 293 increased with the increase of antibody concentration, and the Internalization Rate (%) 75% at antibody concentration of 55 ng/mL.

-25~-15℃保存，有效期1年。